Nordialex
Nordialex Brand names, Nordialex Analogs
- 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea
- 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea
- Diamicron
- Gliclazida [INN-Spanish]
- Gliclazide (JAN)
- Gliclazide [BAN:DCF:INN:JAN]
- Gliclazidum [INN-Latin]
- Glimicron
- Glimicron (TN)
- N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea
- Nordialex
Nordialex Brand Names Mixture
- No information avaliable
Nordialex Chemical_Formula
C15H21N3O3S
Nordialex RX_link
No information avaliable
Nordialex fda sheet
Nordialex msds (material safety sheet)
Nordialex Synthesis Reference
No information avaliable
Nordialex Molecular Weight
323.412 g/mol
Nordialex Melting Point
181 oC
Nordialex H2O Solubility
No information avaliable
Nordialex State
Solid
Nordialex LogP
2.418
Nordialex Dosage Forms
Tablet
Nordialex Indication
For the treatment of Diabetes mellitus
Nordialex Pharmacology
Gliclazide is a second generation sulphonylurea which acts as a hypoglycemic agent. It stimulates beta cells of the islet of Langerhans in the pancreas to release insulin. It also enhances peripheral insulin sensitivity. Overall it potentiates insulin release and improves insulin dynamics.
Nordialex Absorption
Rapidly and well absorbed but may have wide inter- and intra-individual variability.
Nordialex side effects and Toxicity
LD50=3000 mg/kg (orally in mice)
Nordialex Patient Information
No information avaliable
Nordialex Organisms Affected
Humans and other mammals
